Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMDEVIMAB vs IMIQUIMOD: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMDEVIMAB vs IMIQUIMOD: Safety Overview

Metric IMDEVIMAB IMIQUIMOD
Total FAERS Reports 432 1,689
Deaths Reported 24 25
Death Rate 5.6% 1.5%
Hospitalizations 202 154
Average Patient Age 56.2 yrs 62.3 yrs
% Female Patients 52.7% 52.1%
FDA Approval Date N/A Apr 15, 2011
Manufacturer N/A Padagis Israel Pharmaceuticals Ltd
Route N/A TOPICAL
Marketing Status N/A Discontinued